Progress of research on the relationship between hemoglobin variability and prognosis of patients with chronic kidney disease

doi:10.3877/cma.j.issn.2095-3216.2020.05.008

Abstract

Abstract:

The hemoglobin (Hb) level of patients with chronic kidney disease (CKD) can fluctuate frequently in a short period of time, so even if the temporarily detected Hb value is within the treatment target range, the patient′s true Hb level may still be higher or lower than the recommended target level due to frequent fluctuations. At present, the relationship between Hb variability (Hb-Var) and the prognosis of patients with CKD is still inconclusive. This article reviewed recent research progress to explore the relationship between Hb-Var and the prognosis of CKD patients.

Key words: Chronic kidney disease, Hemoglobin variability, Prognosis

Lin Li, Shuxin Liu. Progress of research on the relationship between hemoglobin variability and prognosis of patients with chronic kidney disease[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2020, 09(05): 228-231.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2020.05.008

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2020/V09/I05/228

References 41

[1]	Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease [J]. Lancet, 2017, 389(10075): 1238-1252.
[2]	Padhi S, Glen J, Pordes BAJ, et al. Management of anaemia in chronic kidney disease: summary of updated NICE guidance [J]. BMJ, 2015, 350: h2258.
[3]	张慧然，徐金升，白亚玲，等．维持性血液透析患者贫血治疗达标情况及影响因素研究[J]. 中国全科医学，2016, (19): 2284-2288.
[4]	Mikhail A, Brown C, Williams JA, et al. Renal association clinical practice guideline on anaemia of chronic kidney disease [J]. BMC Nephrol, 2017, 18(1): 345.
[5]	Garimella PS, Katz R, Patel KV, et al. Association of serum erythropoietin with cardiovascular events, kidney function decline, and mortality: the health aging and body composition study [J]. Circ Heart Fail, 2016, 9(1): e002124.
[6]	Hu JP, Cheng X, Xu XF, et al. Reactivity of patients with maintenance hemodialysis to erythropoietin in the treatment of renal anemia [J]. J Biol Regul Homeost Agents, 2016, 30(2): 535-540.
[7]	Zhao L, Hu C, Cheng J, et al. Haemoglobin variability and all-cause mortality in haemodialysis patients: a systematic review and meta-analysis [J]. Nephrology (Carlton), 2019, 24(12): 1265-1272.
[8]	曹雪莹. 维持性腹膜透析患者流行病学调查及预后相关性研究[D]. 中国人民解放军医学院，2015.
[9]	张媛，龙涛，王桂兰，等. 维持性血液透析患者血红蛋白变异性与死亡以及心脑血管事件发生的相关性[J]. 中国公共卫生，2019, 35(3): 368-369.
[10]	Gaweda AE, Aronoff GR, Jacobs AA, et al. Individualized anemia management reduces hemoglobin variability in hemodialysis patients [J]. J Am Soc Nephrol, 2014, 25(1): 159-166.
[11]	钟晓菁，吴青，张丽红，等. 维持性血液透析患者血红蛋白变异与心脑血管事件的关联[J]. 肾脏病与透析肾移植杂志，2017, 26(3): 212-216.
[12]	李萍，陈孜瑾，蒋钻红，等. 血红蛋白检测频率对血红蛋白变异的影响及与血液透析患者预后的关系研究[J]. 中国血液净化，2015, 14(3): 148-151.
[13]	撒利建，马蓓佳，赵瑛瑛. 不同腹膜透析龄患者血红蛋白变异性与心脏结构及功能相关性分析[J]. 中华实用诊断与治疗杂志，2019, 33(1):43-46.
[14]	孙宏鸽，刘启贵，王晓蓉，等. 基于联合模型的谷丙和谷草转氨酶动态变化与代谢综合征的关联研究[J]. 中国卫生统计，2018, 35(2): 181-185.
[15]	Asar O, Ritchie J, Kalra PA, et al. Joint modelling of repeated measurement and time-to-event data: an introductory tutorial [J]．Int J Epidemiol, 2015, 44(1): 334-344.
[16]	Szeto CC, Kwan CH, Chow KM, et al. Haemoglobin variability in Chinese pre-dialysis CKD patients not receiving erythropoietin [J]. Nephrol Dial Transplant, 2011, 26(9): 2919-2924.
[17]	Nicola LD, Minutolo R, Conte G. Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? [J]. Nephron Clin Pract, 2010, 114(4): c236-c241.
[18]	Sumida K, Diskin C, Molnar M, et al. Pre-end-stage renal disease hemoglobin variability predicts post-end-stage renal disease mortality in patients transitioning to dialysis [J]. Am J Nephrol, 2017, 46(5): 397-407.
[19]	魏玮，王慧敏. 肾性贫血变异度对慢性肾脏病患者影响的回顾性分析[J]. 中国综合临床，2015, 31(5):394-397.
[20]	杨小军，张晓东，方敬爱，等. CKD3～5期患者血红蛋白变异度与颈动脉硬化的相关性研究[J]. 中国中西医结合肾病杂志，2019, 20(2): 159-161.
[21]	Gilbertson DT, Hu Y, Peng Y, et al. Variability in hemoglobin levels in hemodialysis patients in the current era: a retrospective cohort study [J]. Clin Nephrol, 2017, 88(11): 254-265
[22]	赵新菊，王芳，左力，等. 患者水平及透析机构水平的血红蛋白变异性对血液透析患者死亡风险的影响[J]. 中国血液净化，2016, 15(6): 357-361.
[23]	何琴，蔡宏，张伟明，等. 维持性血液透析患者贫血状况与预后的关系[J]. 中华肾脏病杂志，2016, 32(2): 110-117.
[24]	Lin FJ, Zhang X, Huang LS, et al. Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients [J]. Int Urol Nephrol, 2018, 50(9): 1703-1712.
[25]	Ganidagli SE, Altunoren O, Erken E, et al. The relation between hemoglobin variability and carotid intima-media thickness in chronic hemodialysis patients [J]. Int Urol Nephrol, 2017, 49(6): 1-8.
[26]	向佳兵，高媛. 高频超声评价血红蛋白变异血液透析患者颈动脉内中膜厚度的临床价值[J]. 河北医药，2019, 41(24): 3742-3745.
[27]	Bal Z, Demirci BG, Karakose S, et al. Factors influencing hemoglobin variability and its association with mortality in hemodialysis patients [J]. ScientificWorldJournal, 2018, 2018: 8065691.
[28]	陈丽娟. 血液透析患者死亡风险与血红蛋白检测频率相关性分析[J]. 临床医学，2018, 38(4): 65-68.
[29]	史春红，李秀娟. 维持性血液透析患者血红蛋白变异性与病死率的相关性研究[J]. 中国全科医学，2016, S1(B12): 181-182.
[30]	应俊，张晓辉，黄坚，等. 慢性肾脏病患者的血红蛋白变异性[J]. 浙江医学，2017, 39(14): 1233-1236.
[31]	龚蓉，皮婧静，陈泽君，等. 维持性腹膜透析与血液透析患者血红蛋白变异性的对比研究[J/CD]. 中华临床医师杂志(电子版), 2014, 8(7):1216-1220.
[32]	Chen HC, Chen KH, Lin YJ, et al. Hemoglobin variability does not predict mortality in peritoneal dialysis patients [J]. Chang Gung Med J, 2012, 35(1): 79-87.
[33]	Jegatheesan D, Cho Y, Johnson DW. Clinical studies of interventions to mitigate cardiovascular risk in peritoneal dialysis patients [J]. Semin Nephrol, 2018, 38(3): 277-290.
[34]	陈雅，倪兆慧，顾乐怡，等. 腹膜透析患者血红蛋白波动与其心血管预后[J]．中国血液净化，2014, 13(6): 428-432.
[35]	Chen Y, Fang W, Gu L, et al. The role of hemoglobin variability as a prognostic indicator in peritoneal dialysis patients: a retrospective descriptive study [J]. Int Urol Nephrol, 2018, 50(1): 167-171.
[36]	段晓星. 维持性血液透析患者血红蛋白变异性与住院率及心血管事件发生的相关性研究[J]. 中国中西医结合肾病杂志，2016, 17(10): 886-887.
[37]	Barbieri C, Molina M, Ponce P, et al. An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients [J]. Kidney Int, 2016, 90(2): 422-429.
[38]	Ho WR, Germain MJ, Garb J, et al. Use of 12×/month haemoglobin monitoring with a computer algorithm reduces haemoglobin variability [J]. Nephrol Dial Transplant, 2010, 25(8): 2710-2714.
[39]	Floege J, Gillespie IA, Kronenberg F, et al. Development and validation of a predictive mortality risk score from a European hemodialysis cohort [J]. Kidney Int, 2015, 87(5): 996-1008.
[40]	王静，孙艳艳. 慢性肾脏病患者血红蛋白变异性的研究进展[J]. 世界最新医学信息文摘，2018, 18(45): 73-74,81.
[41]	陈颖颖，林春华，陈兰，等. 维持性补铁方式对血液透析患者血红蛋白变异度的影响[J]. 中华全科医学，2018, 16(3): 419-422.

Please choose a citation manager

Content to export